Surgery Partners Inc (SGRY) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Surgery Partners Inc   (NASDAQ: SGRY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Surgery Partners Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Surgery Partners Inc's ROI in the second quarter of 2026?
Surgery Partners Inc achieved a return on average invested assets (ROI) of 1.02 % in its second quarter of 2026, which is below Surgery Partners Inc's average return on investment, which stands at 1.2%.

ROI fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

Within the Healthcare sector 177 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 2258, from total ROI ranking in the first quarter of 2026 at 2573.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 16.32 % 3.83 % 7.06 % 9.7 % 11.23 %
Y / Y Net Income Change TTM 1761.36 % - - -33.05 % -84.51 %
Investment (TTM) in Millions 10,895 7,095 7,130 7,014 7,044
Return On Investment (TTM) 1.02 % 1.37 % 1.4 % 0.33 % 0.06 %
SGRY's Overall Ranking # 2258 # 2573 # 2483 # 2514 # 2567
Seq. Investment Change TTM 13.62 % 0.22 % 0.81 % 1.34 % 1.42 %
Seq. Net Income Change TTM -15.65 % -1.82 % 324.46 % 429.55 % -
Net Income (TTM) in Millions 82 97 99 23 4




Return On Investment SGRY's Ranking
Within: No.
Industry # 22
Sector # 178
Overall # 2258

Return On Investment Statistics
High Average Low
4.09 %
1.2 %
-2.08 %
(Dec 31 2015)   (Mar 31 2019)







Financial Statements
Surgery Partners Inc's II. Quarter Investments $ 10,895 Millions SGRY's Balance sheet
Surgery Partners Inc's II. Quarter Income $ 30 Millions Quarterly SGRY's Income Statement
SGRY's Income by Division See SGRY's Income by Division


SGRY Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 7,130 6,904 6,064 5,842 5,911
Y / Y Investment Growth 3.27 % 13.86 % 3.8 % -1.17 % 14.48 %
Net Income in Millions 99 13 135 87 71
Y / Y Net Income Growth 691.2 % -90.76 % 55.52 % 23.06 % 5338.46 %
Annual Return On Investment 1.39 % 0.18 % 2.23 % 1.49 % 1.2 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 1.39 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGRY's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGRY's Competitors
Subscribers only: Roi for Surgery Partners Inc's Suppliers
Subscribers only: Return On Investment for SGRY's Customers

Other Ratios
SGRY's Roa SGRY's Inventory Turnover Ratio SGRY's Growth Rates SGRY's Dividend Statistics
SGRY's Profitability Ratios SGRY's Asset Turnover Ratio SGRY's Dividend Growth
SGRY's Roe SGRY's Valuation Ratios SGRY's Financial Strength Ratios SGRY's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %
Cormedix Inc   1.31 %
Pacira Biosciences inc   1.29 %
Waters Corporation  1.20 %
Surgery Partners Inc   1.02 %
Warby Parker Inc   0.98 %
Staar Surgical Co  0.98 %
Biomarin Pharmaceutical Inc  0.91 %
Icu Medical Inc  0.87 %
Radnet Inc   0.45 %
Delcath Systems Inc   0.45 %


Date modified: 2026-09-08T22:14:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.